Abstract
Vulvar cancer accounts for only 5% of all gynecologic cancers with an incidence rate of 2.4 per 100,000 women. The most common histological type of vulvar cancer is vulvar squamous cell carcinoma (VSCC). There are two different types of VSCC with their own associated premalignant lesions. The most common type occurs in elderly women and leads to mostly differentiated keratinizing VSCC in a background of lichen sclerosus and often differentiated vulvar intraepithelial neoplasia. The second type of VSCC consists of mainly nonkeratinizing carcinomas, primarily affecting younger women, and is associated with high-grade squamous intraepithelial lesions. The diagnosis VSCC should be confirmed histologically, preferably by a punch biopsy. The method of treatment for VSCC depends on the extent of the disease. In general, surgery is the first choice of treatment in patients with primary VSCC. The inguinofemoral lymph node status at initial diagnosis reflected in stage is of critical prognostic importance for patients with VSCC. The treatment of VSCC consists of radical local excision of the tumor combined with the sentinel node procedure in patients with early-stage unifocal tumors of less than 4 cm and without clinically suspicious groin lymph nodes. In case of a metastatic sentinel node, a larger or multifocal tumor, or clinically suspicious lymph nodes, an inguinofemoral lymphadenectomy is indicated. There is a limited role for primary radio- and/or chemotherapy. Overall survival for early-stage VSCC patients is good with 75% at 5 years.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S. 2016. SEER cancer statistics review, 1975–2012. [Online]. Available: http://seer.cancer.gov/csr/1975_2012.
Pleunis N, Schuurman MS, Van Rossum MM, Bulten J, Massuger LF, de Hullu JA, Van der Aa MA. Rare vulvar malignancies; incidence, treatment and survival in the Netherlands. Gynecol Oncol. 2016;142(3):440–5.
Schuurman MS, Van den Einden LC, Massuger LF, Kiemeney LA, Van der Aa MA, de Hullu JA. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. Eur J Cancer. 2013;49:3872–80.
Bornstein J, Bogliatto F, Haefner HK, Stockdale CK, Preti M, Bohl TG, Reutter J. The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology of vulvar squamous intraepithelial lesions. Obstet Gynecol. 2016;127:264–8.
Van de Nieuwenhof HP, Van der Avoort IA, de Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol. 2008;68:131–56.
de Hullu JA, Hollema H, Piers DA, Verheijen RH, Van Diest PJ, Mourits MJ, Aalders JG, Van der Zee AG. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol. 2000;18:2811–6.
Gaarenstroom KN, Kenter GG, Trimbos JB, Agous I, Amant F, Peters AA, Vergote I. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer. 2003;13:522–7.
Oonk MH, Van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, Van Dorst EB, Van der Velden J, Hermans RH, Van der Putten HW, Drouin P, Runnebaum IB, sluiter WJ, Van der Zee AG. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 2010;11:646–52.
Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Maisonneuve P, Pecorelli S, Odicino F, Heintz AP. Carcinoma of the vulva. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S7–27.
Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol. 1983a;61:408–12.
Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.
de Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MP, Aalders JG, Mourits MJ, Van der Zee AG. Vulvar carcinoma. The price of less radical surgery. Cancer. 2002;95:2331–8.
Hacker NF, Leuchter RS, Berek JS, Castaldo TW, Lagasse l D. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58:574–9.
Hacker NF, Nieberg RK, Berek JS, Leuchter RS, Lucas WE, Tamimi HK, Nolan JF, Moore JG, Lagasse LD. Superficially invasive vulvar cancer with nodal metastases. Gynecol Oncol. 1983b;15:65–77.
Hacker NF, Van der Velden J. Conservative management of early vulvar cancer. Cancer. 1993;71:1673–7.
Hopkins MP, Reid GC, Morley GW. Radical vulvectomy. The decision for the incision. Cancer. 1993;72:799–803.
Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL, Bell MC, de Geest K, Spirtos NM, Potkul RK, Leitao MM Jr, Bakkum-Gamez JN, Rossi EC, Lentz SS, Burke JJ 2nd, Van Le L, Trimble CL. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012;30:3786–91.
Podratz KC, Symmonds RE, Taylor WF, Williams TJ. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol. 1983;61:63–74.
Van der Zee AG, Oonk MH, de Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, Van Dorst EB, Van der Velden J, Hermans RH, Van der Putten H, Drouin P, Schneider A, Sluiter WJ. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9.
Magrina JF, Gonzalez-Bosquet J, Weaver AL, Gaffey TA, Leslie KO, Webb MJ, Podratz KC. Squamous cell carcinoma of the vulva stage IA: long-term results. Gynecol Oncol. 2000;76:24–7.
Yoder BJ, Rufforny I, Massoll NA, Wilkinson EJ. Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk. Am J Surg Pathol. 2008;32:765–72.
Oonk MH, Van der Zee AG. Sentinel node mapping and groin dissection. In: Abu-Rustum N, Barakat R, Levine D, editors. Atlas of procedures in gynecologic oncology. 3rd ed. Boca Raton: Tayler & Francis Group; 2013.
Nooij LS, Van der Slot MA, Dekkers OM, Stijnen T, Gaarenstroom KN, Creutzberg CL, Smit VT, Bosse T, van Poelgeest MI. Tumour-free margins in vulvar squamous cell carcinoma: does distance really matter? Eur J Cancer. 2016b;65:139–49.
Yap JK, Fox R, Leonard S, Ganesan R, Kehoe ST, Dawson CW, Woodman CB, Luesley DM. Adjacent lichen sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma. Gynecol Oncol. 2016;42(3):420–6.
Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol. 2008;108:577–83.
Te Grootenhuis NC, Van der Zee AG, Van Doorn HC, Van der Velden J, Vergote I, Zanagnolo V, Baldwin PJ, Gaarenstroom KN, Van Dorst EB, Trum JW, Slangen BF, Runnebaum IB, Tamussino K, Hermans RH, Provencher DM, de Bock GH, de Hullu JA, Oonk MH. Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol. 2016;140:8–14.
Oonk MH, Hollema H, de Hullu JA, Van der Zee AG. Prediction of lymph node metastases in vulvar cancer: a review. Int J Gynecol Cancer. 2006;16:963–71.
de Hullu JA, Piers DA, Hollema H, Aalders JG, Van der Zee AG. Sentinel lymph node detection in locally recurrent carcinoma of the vulva. BJOG. 2001;108:766–8.
Ennik TA, Allen DG, Bekkers RL, Hyde SE, Grant PT. Effects of previous surgery on the detection of sentinel nodes in women with vulvar cancer. Int J Gynecol Cancer. 2011;21:1679–83.
Landkroon AP, de Hullu JA, Ansink AC. Repeat sentinel lymph node procedure in vulval carcinoma. BJOG. 2006;113:1333–6.
Van Doorn HC, Van Beekhuizen HJ, Gaarenstroom KN, Van der Velden J, Van der Zee AG, Oonk MH, de Hullu JA. Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible. Gynecol Oncol. 2016;140:415–9.
Woelber L, Grimm D, Vettorazzi E, Wisotzki C, Trillsch F, Jaenicke F, Schwarz J, Choschzick M, Mahner S. Secondary sentinel node biopsy after previous excision of the primary tumor in squamous cell carcinoma of the vulva. Ann Surg Oncol. 2013;20:1701–6.
Oonk MH, de Hullu JA, Van der Zee AJ. Letter to the editor on “the importance of performing a sentinel node biopsy in case of recurrent vulvar cancer”. Int J Gynecol Cancer. 2014;24:1537.
Maggino T, Landoni F, Sartori E, Zola P, Gadducci A, Alessi C, Solda M, Coscio S, Spinetti G, Maneo A, Ferrero A, Konishi de Toffoli G. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer. 2000;89:116–22.
Woolderink JM, de Bock GH, de Hullu JA, Davy MJ, Van der Zee AG, Mourits MJ. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol. 2006;103:293–9.
Nooij LS, Brand FA, Gaarenstroom KN, Creutzberg CL, de Hullu JA, Van Poelgeest MI. Risk factors and treatment for recurrent vulvar squamous cell carcinoma. Crit Rev Oncol Hematol. 2016a;106:1–13.
Tantipalakorn C, Robertson G, Marsden DE, Gebski V, Hacker NF. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol. 2009;113:895–901.
Gadducci A, Tana R, Barsotti C, Guerrieri ME, Genazzani AR. Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva. Crit Rev Oncol Hematol. 2012;83:71–83.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Pouwer, AF.W., te Grootenhuis, N.C., Oonk, M.H.M., de Hullu, J.A. (2019). Vulvar Carcinoma: Diagnosis, Staging, and Treatment. In: Bornstein, J. (eds) Vulvar Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-61621-6_58
Download citation
DOI: https://doi.org/10.1007/978-3-319-61621-6_58
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61620-9
Online ISBN: 978-3-319-61621-6
eBook Packages: MedicineMedicine (R0)